+15075562445 (US)
sales@htfmarketintelligence.com
Published: Oct 10, 2025
ID: 2410706
110 Pages
Invertase

Invertase Market Shaping Ahead to Long-Term Value Realization

Global Invertase Market is segmented by Application (Food & Beverage, Pharmaceuticals, Cosmetics, Biofuels, Medical Research), Type (Plant-based, Yeast, Fungal, Microbial, Recombinant), and Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

Report ID:
HTF2410706
Published:
CAGR:
7%
Market Size (2023):
$0.5Billion
Forecast (2031):
$1.2Billion

Pricing

Report Overview

Industry Overview


The Invertase market is witnessing significant growth and is expected to expand at a CAGR of 7% during the forecast period from 2023 to 2031. This growth is primarily driven by increasing technological advancements, rising consumer demand, and expanding applications across various industries. Businesses are increasingly adopting innovative solutions to improve operational efficiency, enhance customer experiences, and gain a competitive advantage, further fueling market expansion.
Invertase Market Compound Annual Growth Rate 2023-2031

Source: HTF Market Intelligence (HTF MI)

Invertase is an enzyme that is commonly used to make candy liquid centers_ chocolate-covered cherries_ fondant candies_ creme eggs_ and other cordials. It is commonly derived from yeast_ either from bread factories or beer breweries and sold either as a clear liquid or as a powder that can be dissolved in water. When invertase is added to sugar candy recipes_ like fondant candy fillings_ it progressively liquefies the fondant and is one way of producing the liquid center in candies like cherry cordials. The exact amount of invertase required depends on numerous factors which include the strength and preparation of the invertase_ the temperature of the environment_ and the recipe itself.
The research study Invertase Market gives readers information on tactical business choices and strategic planning that affect and stabilize the growth prediction in the Invertase market. However, a few disruptive trends will have opposite and significant effects on the distribution among players and the growth of the Invertase market. To give further advice on why certain developments in the Invertase market would have a significant impact and specifically why these trends can be taken into account when determining the market's trajectory and industry participants' strategic plans.

Key Highlights


•    The Invertase is growing at a CAGR of 7% during the forecasted period of 2023 to 2031
• Year-on-year growth for the market is 5%.
•   N/A  dominated the market share in 2023
•    Based on type, the market is bifurcated into the Plant-based, Yeast, Fungal, Microbial, Recombinant segment, which dominated the market share during the forecasted period
• Based on application, the market is segmented into Application Food & Beverage, Pharmaceuticals, Cosmetics, Biofuels, Medical Research as the fastest-growing segment.
• North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA import/export in terms of K tons, K units, and metric tons will be provided if applicable, based on industry best practices.

Market Dynamics Highlighted


Market Driver

The Invertase market is experiencing significant growth due to various factors.

  • Potential Growth Offered by Emerging Economies

Market Trend


The Invertase market is growing rapidly due to various factors.

  • Enzyme Engineering
  • Natural Sources

Opportunity


The Invertase has several opportunities, particularly in developing countries where industrialization is growing.

  • Potential Growth Offered by Emerging Economies

Challenge


The market for fluid power systems faces several obstacles despite its promising growth possibilities.

  • Regulatory Constraints
  • Production Costs

 

Invertase Market Segment Highlighted


Segmentation by Type


  • Plant-based
  • Yeast
  • Fungal
  • Microbial
  • Recombinant
Invertase Market trend and sizing by Plant-based, Yeast, Fungal, Microbial, Recombinant

Segmentation by Application

  • Food & Beverage
  • Pharmaceuticals
  • Cosmetics
  • Biofuels
  • Medical Research

Invertase Market segment share by Food & Beverage, Pharmaceuticals, Cosmetics, Biofuels, Medical Research

Key Players


The companies featured in this profile were selected based on insights from primary experts, evaluating their market penetration, product offerings, and geographical reach. By targeting emerging markets, these companies aim to leverage new opportunities, enhance their competitive advantage, and drive revenue growth. This approach not only aligns with their overall business objectives but also positions them to respond effectively to the evolving demands of consumers in these regions. Several key players in the Invertase market are strategically focusing on expanding their operations in developing regions to capture a larger market share, particularly as the year-on-year growth rate for the market stands at 5%.
  • Sigma-Aldrich Co. LLC (United States)
  • DSM (Netherlands)
  • Parchem Fine & Specialty Chemicals (United States)
  • SternEnzym GmbH & Co. KG (Germany)
  • Kerry Inc. (Ireland)
  • Meteoric Exim Private Limited (India)
  • MP Biomedicals
  • LLC (United States)
  • BIO-CAT (United States)
  • Megazyme Inc. (Ireland)
Invertase Market share of Sigma-Aldrich Co. LLC (United States), DSM (Netherlands), Parchem Fine & Specialty Chemicals (United States), SternEnzym GmbH & Co. KG (Germany), Kerry Inc. (Ireland), Meteoric Exim Private Limited (India), MP Biomedicals, LLC (United States), BIO-CAT (United States), Megazyme Inc. (Ireland)


 
Need More Details on Market Players and Competitors?

Regional Insight


The N/A dominant region currently dominates the market share, fueled by increasing consumption, population growth, and sustained economic progress, which collectively enhance market demand. Conversely, the N/A is growing rapidly, driven by significant infrastructure investments, industrial expansion, and rising consumer demand.

  • North America
  • LATAM
  • West Europe
  • Central & Eastern Europe
  • Northern Europe
  • Southern Europe
  • East Asia
  • Southeast Asia
  • South Asia
  • Central Asia
  • Oceania
  • MEA
Loading map...

Market Entropy


Merger & Acquisition


Patent Analysis


Investment and Funding Scenario


Report Infographics

Report Features Details
Base Year 2023
Based Year Market Size (2023) 0.5Billion
Historical Period 2019 to 2023
CAGR (2023 to 2031) 7%
Forecast Period 2026 to 2031
Forecasted Period Market Size (2031) 1.2Billion
Scope of the Report

By Type, By Application, By Region

Companies Covered Sigma-Aldrich Co. LLC (United States), DSM (Netherlands), Parchem Fine & Specialty Chemicals (United States), SternEnzym GmbH & Co. KG (Germany), Kerry Inc. (Ireland), Meteoric Exim Private Limited (India), MP Biomedicals, LLC (United States), BIO-CAT (United States), Megazyme Inc. (Ireland)
Customization Scope 15% Free Customization
Want to Buy Specific Sections of This Report?
Delivery Format PDF and Excel through Email
   

The Top-Down and Bottom-Up Approaches

 
The top-down approach begins with a broad theory or hypothesis and breaks it down into specific components for testing. This structured, deductive process involves developing a theory, creating hypotheses, collecting and analyzing data, and drawing conclusions. It is particularly useful when there is substantial theoretical knowledge, but it can be rigid and may overlook new phenomena. 
Conversely, the bottom-up approach starts with specific data or observations, from which broader generalizations and theories are developed. This inductive process involves collecting detailed data, analyzing it for patterns, developing hypotheses, formulating theories, and validating them with additional data. While this approach is flexible and encourages the discovery of new phenomena, it can be time-consuming and less structured. 

Regulatory Framework


The healthcare sector is overseen by various regulatory bodies that ensure the safety, quality, and efficacy of health services and products. In the United States, the U.S. Department of Health and Human Services (HHS) plays a crucial role in protecting public health and providing essential human services. Within HHS, the Food and Drug Administration (FDA) regulates food, drugs, and medical devices, ensuring they meet safety and efficacy standards. The Centers for Disease Control and Prevention (CDC) focuses on disease control and prevention, conducting research, and providing health information to protect public health.